Fund overlap
SBI HEALTHCARE OPPORTUNITIES FUND vs HDFC Pharma and Healthcare Fund
Fund A
SBI HEALTHCARE OPPORTUNITIES FUND
SBI HEALTHCARE OPPORTUNITIES FUND - Direct Plan - IDCW
Open Ended Schemes(Equity Scheme - Sectoral/ Thematic) · SBI Mutual Fund
Fund B
HDFC Pharma and Healthcare Fund
HDFC Pharma and Healthcare Fund - Direct Plan - IDCW Option
Open Ended Schemes(Equity Scheme - Sectoral/ Thematic) · HDFC Mutual Fund
Overlap
34.1%
- Shared holdings
- 18
- Holdings in A
- 37
- Holdings in B
- 39
Overlap measures how closely the two portfolios match, holding by holding and weight by weight, using each fund's latest disclosed holdings. 100% would mean the same holdings at the same weights.
Shared holdings
The 10 largest of 18 shared holdings, ordered by the smaller of the two weights.
| Holding | SBI HEALTHCARE OPPORTUNITIES FUND | HDFC Pharma and Healthcare Fund |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.14% | 8.28% |
| Divi's Laboratories Ltd. | 7.91% | 9.39% |
| Cipla Ltd. | 4.40% | 4.15% |
| Apollo Hospitals Enterprise Ltd. | 4.45% | 3.69% |
| Torrent Pharmaceuticals Ltd. | 4.42% | 3.65% |
| Max Healthcare Institute Ltd. | 3.80% | 3.61% |
| Aster DM Quality Care Ltd. | 3.21% | 3.56% |
| Acutaas Chemicals Ltd. | 5.03% | 3.18% |
| Anthem Biosciences Ltd. | 2.75% | 3.17% |
| Gland Pharma Ltd. | 2.96% | 1.78% |
Data as of 30 Sept 2026
Method: weighted Jaccard
Weighted Jaccard adds up the smaller weight of every holding across both funds and divides by the sum of the larger weights.